Cancer Vaccine Maker Therion Is Up For Sale After Disappointing Phase III Results
This article was originally published in The Pink Sheet Daily
Executive Summary
Therion no longer plans to submit a BLA for its PANVAC-VF pancreatic cancer treatment.